CE
CEN Biotech, Inc.
CENBF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $6.53K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.01x
PEG N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 153.48%
Op. margin 128.15%
FCF margin 47.11%
Quality
2 /100
Poor ROA 19.28%
Asset turnover 0.13x
ROIC 43.09%
Debt
50 /100
Moderate Int. coverage -4.99x
Net debt/EBITDA -6.65x
Current ratio 0.03x
Stability
19 /100
Unstable EPS volatility 219.27%
Profitable years 0
Beta -4.98x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CENBF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Brian S. Payne
Employees
4
Headquarters
Windsor